search button
Open Access

Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer

  • Authors:
    • Junchi Yang
    • Lumin Bo
    • Ting Han
    • Dan Ding
    • Mingming Nie
    • Kai Yin

  • View Affiliations

  • Published online on: March 9, 2018     https://doi.org/10.3892/mmr.2018.8722
  • Pages: 6345-6356

  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Gastric cancer (GC) has a high incidence and mortality rate. If discovered late, GC tends to have a poor prognosis. Improvements in the prognostic accuracy of GC through combined analysis of multiple relevant genes and clinical factors may solve this problem. In the present study, GSE62254 (including 300 GC tissues), obtained from the Gene Expression Omnibus database, was used as a training set, and the mRNA‑sequencing data of GC (including 384 GC tissues) downloaded from the Cancer Genome Atlas database served as a validation set. Based on the t‑test and Wilcoxon test, the significantly differentially expressed genes (DEGs) were obtained by screening the intersecting DEGs. The prognosis-associated genes and clinical factors were identified using Cox regression analysis in the R survival package. The optimal prognosis‑associated pathways were examined using the Cox‑proportional hazards (Cox‑PH) model in the R penalized package. Finally, risk prediction models were constructed and validated using the Cox‑PH model and the Kaplan‑Meier method, respectively. There were a total of 382 significant DEGs, including 268 upregulated genes and 114 downregulated genes. A total of 50 prognosis‑associated genes were identified, 16 optimal prognosis‑associated pathways (including mitochondrial pathway and the tyrosine‑protein kinase JAK‑signal transducer and activator of transcription signaling pathway, which involve caspase 7, phosphoinositide‑3‑kinase regulatory subunit 3, peroxisome proliferator‑activated receptor γ and collagen triple helix repeat containing 1) and four prognosis‑associated clinical factors [including Pathologic_N, Pathologic_stage, mutL homolog 1 (MLH1) mutation and recurrence]. The pathway‑ and clinical‑factor‑based risk prediction model exhibited marked prognostic accuracy. The clinical‑factor‑based risk prediction model with improved P‑values for prognosis prediction may be superior to the pathway‑based risk prediction model in predicting the prognosis of GC patients.
View Figures
View References

Related Articles

Journal Cover

May-2018
Volume 17 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
  • CiteScore: 6.9
  • CiteScore Rank: Q2: #98/328 Biochemistry, Genetics and Molecular Biology
  • Source Normalized Impact per Paper (SNIP): 0.721
  • SCImago Journal Rank (SJR): 0.65
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Yang J, Bo L, Han T, Ding D, Nie M and Yin K: Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer. Mol Med Rep 17: 6345-6356, 2018
APA
Yang, J., Bo, L., Han, T., Ding, D., Nie, M., & Yin, K. (2018). Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer. Molecular Medicine Reports, 17, 6345-6356. https://doi.org/10.3892/mmr.2018.8722
MLA
Yang, J., Bo, L., Han, T., Ding, D., Nie, M., Yin, K."Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer". Molecular Medicine Reports 17.5 (2018): 6345-6356.
Chicago
Yang, J., Bo, L., Han, T., Ding, D., Nie, M., Yin, K."Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer". Molecular Medicine Reports 17, no. 5 (2018): 6345-6356. https://doi.org/10.3892/mmr.2018.8722